/ WHO WE ARE
RiverVest is a leading venture capital firm building life science companies to address significant unmet medical needs.
8
FUNDS
Since 2000
/ EXPERT INSIGHT
Diabetes Treatment: A Story of Complicated Progress and Great Potential
RiverVest Managing Director Derek Rapp discusses the global health threat of diabetes and shares his thoughts on the innovation ecosystem that is essential to achieving better outcomes for patients.
/ NEWS
ST. LOUIS–(December 12, 2024)— RiverVest Venture Partners, a leading life science venture capital firm, today announced that John C. Cambier, Ph.D., and Gary De Crescenzo have joined the firm’s Scientific Advisory Board. Composed of leaders in medical research, RiverVest’s Scientific Advisory Board provides expert guidance to the firm as it identifies and invests in promising biopharmaceutical and medical device companies.
/ EXPERT INSIGHT
RiverVest speaks with Lyn Baranowski, CEO of portfolio company Avalyn Pharma, about who she is, what brought her to Avalyn, and what fuels her passion for building great companies.
30
COMMERCIAL PRODUCTS
Currently Treating Patients
RiverVest strives to improve the lives of patients, support entrepreneurs, and earn the trust of investors through science, strategy, and innovation.
Contact us at info@rivervest.com
Transparency in Coverage Rule: To access the machine-readable files created and published by United Healthcare, please click here.
© Copyright 2024 RiverVest® All Rights Reserved. | Privacy Policy
Subscribe to our newsletter